Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic to Test Stalled Pfizer Drug Candidates for New Indications

NEW YORK, Sept. 27 (GenomeWeb News) - Gene Logic will help Pfizer find new therapeutic indications for a number of its stalled drug candidates, Gene Logic said today.

 

Under the "drug repositioning program," Gene Logic will test drug candidates from Pfizer that are no longer in development for their potential use across a wide spectrum of diseases areas, using its genomics and in silico technologies as well as technologies it acquired from Millennium Pharmaceuticals last year. Gene Logic is eligible for milestone payments and royalties on drugs that are commercialized as a result of the program.

 

The companies did not disclose other terms of the agreement.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.